• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Graphic of two hands trying to untangle a thread inside someones head
Marketing

Gilead rolls out disease-specific wellness tools with Calm app

Sleep app Calm is helping Gilead achieve its dream of helping its patients through a journey of whole-person health.
Zoey Becker Oct 5, 2026 11:57am
For biopharma manufacturing at speed and scale the future is flexible

For biopharma manufacturing at speed and scale, the future is flexible

Brought to you by Resilience
acquisitions

Shionogi acquires IntraBio to bolster rare disease business

Oct 5, 2026 11:33am
Advancing Treatment A Closer Look at ADT  Darolutamide with Dr Rana McKay

Advancing mCSPC Treatment: A Closer Look at ADT + Darolutamide with Dr. Rana McKay

Brought to you by Bayer
yellow traffic light

Novo cites production site corrections amid hemophilia FDA delay

Oct 5, 2026 7:15am
panel about heart health

BridgeBio gears up for YouTube ATTR-CM awareness push

Oct 5, 2026 6:00am
More News

FDA dings Evolus for blurred lines between Botox rival, lipstick

Oct 5, 2026 5:35am

Lilly’s BTK drug Jaypirca enters first-line CLL

Oct 2, 2026 4:15pm

Bayer doubles down on US with $2.2B Ohio manufacturing project

Oct 2, 2026 3:10pm
Fierce Healthcare

HRSA taps Pfizer, AbbVie, others for revised 340B rebate pilot

Oct 2, 2026 1:00pm
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings